{
    "nctId": "NCT03193008",
    "briefTitle": "Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?",
    "officialTitle": "Current Value of Axillary Ultrasound in the Staging of Breast Cancer. Is BSGC Still Necessary?",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 1400,
    "primaryOutcomeMeasure": "Detection of axillary tumor burden by axillary ultrasound",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u2265 18 years\n* Tumors with ACOSOG Z0011 criteria, except positive SLNB (cT1-T2; cN0; breast-conserving surgery; Whole-Breast Radiotherapy)\n* Axillary study with AUS/FNAC.\n* SLNB/ALND (Gold-Standard).\n\nExclusion Criteria:\n\n* Tumors without confirmation of axillary histologic status (No Gold-Standard)\n* Tumor in pregnancy or breastfeeding.\n* Tumors in the male.\n* Tumors treated with neoadjuvant chemotherapy\n* Tumors that do not meet ACOSOG Z0011 criteria.\n* Tumors without axillary study using AUS/FNAC",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}